NCT06930547

Brief Summary

Smoking is an important psychosocial problem that concerns society. It is reported that 1.3 billion people use tobacco products in the world and approximately 6 million people lose their lives due to smoking every year. Despite the high mortality rate, smoking addiction is shown as one of the biggest preventable diseases and causes of death. Individuals with mental health problems have a much higher smoking rate than the general population. Studies show that people with severe mental disorders such as schizophrenia, bipolar disorder and major depression have a smoking rate three to four times higher than the general population. It has been reported that this high smoking rate is associated with more morbidity, mortality and increased healthcare costs in individuals with severe mental disorders. It is reported that nurses, who spend the most time with patients and constitute the largest group of healthcare personnel, have an effective role in smoking cessation initiatives. The importance of nurses in tobacco control is emphasized in the publication titled "Nurses for a Tobacco-Free Life" by the International Council of Nursing (ICN). Although both national and international literature demonstrates that smoking is a serious problem in individuals with severe mental illness through descriptive research results, it is seen that smoking cessation intervention studies are quite limited. Randomized controlled intervention studies examining the effectiveness of smoking cessation interventions applied by nurses to individuals with severe mental illnesses could not be found in the literature. This study will be conducted to examine the effectiveness of smoking cessation education in patients registered in a community mental health center. In light of this information, this study was planned as a randomized controlled study to examine the effectiveness of smoking cessation education in patients registered in a community mental health center. The data obtained from this study will reveal the effectiveness of smoking cessation education in individuals with severe mental illnesses and contribute to filling the gap in the literature in this area. In addition, a method for using smoking cessation education in individuals with severe mental illnesses will be presented with a high level of evidence study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 16, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

April 9, 2025

Last Update Submit

April 9, 2025

Conditions

Keywords

Tobacco Use DisorderMental DisordersSmoking Cessation

Outcome Measures

Primary Outcomes (2)

  • Fagerström Test for Nicotine Dependence (FTND):

    Developed in 1991 by Heatherton and colleagues (Heatherton et al., 1991), the FTND is a self-assessment scale used to evaluate individuals' risk of physical nicotine dependence, measure the level and intensity of addiction. It includes binary and four-point Likert-type questions, ranging between 0-1 and 0-3. The test consists of six questions, and the total score can range from 0 to 10 points. Based on the score, individuals are categorized as follows: 0-2 points: "Very low dependence" 3-4 points: "Low dependence" 5 points: "Moderate dependence" 6-7 points: "High dependence" 8-10 points: "Very high dependence" (Uysal et al., 2004; Güneş Ersoy, 2019).

    Pre-test before the training, Post-test immediately after the training, 1st follow-up 1 month after the training, 2nd follow-up 3 months after the 1st follow-up

  • Self-Efficacy Scale

    According to Karancı, the Self-Efficacy Scale (SES) was developed in 1984 by Nicki and colleagues. Based on social learning theories, the concept relates to an individual's belief in their ability to perform a desired behavior. Strengthening this belief is frequently used in smoking cessation efforts. The validity and reliability studies of the Self-Efficacy Scale were conducted by Karancı (1992). The scale consists of 25 items, and each item is rated on a 1-5 scale, with the options ranging from "Not sure at all: 1" to "Absolutely sure: 5". The total score ranges from 25 to 125. A higher score reflects a stronger belief in the ability to quit smoking. As the score increases, so does the belief in one's ability to quit smoking (Karancı, 1992).

    Pre-test before the training, Post-test immediately after the training, 1st follow-up 1 month after the training, 2nd follow-up 3 months after the 1st follow-up

Study Arms (2)

control group

NO INTERVENTION

This group will not receive the smoking cessation training.

İntervention

EXPERIMENTAL

Smoking cessation training will be applied to this group

Other: Experimental

Interventions

In this study, the experimental group will undergo a smoking cessation training program consisting of eight sessions over four weeks, conducted twice a week. Each session is planned to last approximately 40-45 minutes. During the program, before each session, the previous session will be reviewed to reinforce learning and establish continuity between sessions. Feedback will be collected to ensure engagement and comprehension. At the end of each session, a summary of the session's agenda will be provided. Before each session, both the experimental and control groups will be evaluated using a smoking cessation status form to assess their progress. Additionally, follow-up assessments will be conducted one month and three months after the program to test the retention of the training's effectiveness.

İntervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being registered with TRSM (Community Mental Health Center)
  • Being in the remission phase (the period after the patient's treatment is completed, with no observed active symptoms and improved insight)
  • Smoking at least one cigarette per day regularly
  • Being open to communication and collaboration
  • Being over the age of 18
  • Volunteering to participate in the study.

You may not qualify if:

  • Not being registered with TRSM (Community Mental Health Center)
  • Not being in the remission phase (presence of active symptoms or lack of improved insight)
  • Smoking less than one cigarette per day
  • Being unwilling or unable to communicate and collaborate effectively
  • Being under the age of 18
  • Not volunteering or unwilling to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erzurum Community Mental Health Center

Erzurum, Erzurum, 25050, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Tobacco Use DisorderMental DisordersSmoking Cessation

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersHealth BehaviorBehavior

Study Officials

  • Zeynep ÖZTÜRK, PHD

    Erzurum Technical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zeynep ÖZTÜRK, PHD

CONTACT

Ayşe METİN, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Experimental group Control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2025

First Posted

April 16, 2025

Study Start

December 5, 2024

Primary Completion

May 5, 2025

Study Completion

August 15, 2025

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations